MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Comparison of cognitive and neuropsychological manifestations in patients with progressive supranuclear palsy (Psp) and Parkinson’s disease

    M.U. Kulsum, S.S. Anand, S. Chatterjee, P. Chatterjee, B. Mondal, S. Choudhury, K. Chatterjee, R. Banerjee, S.S. Jha, H. Kumar (Kolkata, India)

    Objective: 1) To compare the cognitive and neuropsychological manifestations between the patients with PSP and PD. 2) To find out the severity of caregivers distress…
  • 2016 International Congress

    Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

    P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

    Objective: To evaluate the prevalence, interrelation and impact on health related quality of life (HRQL) and Activities of daily Living (ADL) of motor (MS) and…
  • 2016 International Congress

    Staging and clinical correlates of cortical thinning in Parkinson’s disease

    H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis (London, United Kingdom)

    Objective: By using a novel disease staging model to investigate the progression and clinical associations of cortical thinning in Parkinson's disease (PD) patients. Background: The…
  • 2016 International Congress

    Suicide attempts and Huntington’s disease: Perseveration, not just impulsivity

    O.C. Roman, J.G. Stovall, D.O. Claassen (Nashville, TN, USA)

    Objective: To present the hypothesis that perseveration, not just impulsivity, is a risk factor for suicide attempts in Huntington's disease (HD). Background: The elevated incidence…
  • 2016 International Congress

    The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson’s disease

    B.A. Pickut, W. Van Hecke, P. Cras, E. Kerckhofs, S. Vanneste, D. Crosiers, P. Marien, P.M. Parizel (Grand Rapids, MI, USA)

    Objective: The aim of the current study is to investigate the effect of an eight-week mindfulness training intervention on emotion related brain activation in people…
  • 2016 International Congress

    Cognitive deficits in Parkinson’s disease: A preliminary study of neuropsychological profiles

    R.J. Giannaula, P.G. Sanz, J.C. Maiques, M.B. Seijas, M.J. González Aguilar, L. Grasso (Buenos Aires, Argentina)

    Objective: The purpose of this project was to examine cognitive deficits in a patient sample fulfilling the diagnostic criteria for idiopathic non-demented Parkinson's disease (PD)…
  • 2016 International Congress

    Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

    H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)

    Objective: We examined the effects of dopaminergic medication adjustment on cognitive function in Parkinson's disease (PD) patients without apparent dementia (Mini-Mental State Examination score of…
  • 2016 International Congress

    Executive function and verbal fluency in patients with Parkinson’s disease

    A.F. Barbosa, M.C. Voos, C.O. Souza, J. Chen, H.F. Chien, D.V. Francato, E.R. Barbosa, L.L. Mansur (São Paulo, Brazil)

    Objective: To determine whether the phonemic verbal fluency test is a purely cognitive measure or involves cognitive-motor interaction, if related to TMT. Background: Two of…
  • 2016 International Congress

    Monoaminergic biomarkers of cognitive decline in Parkinson’s disease and Lewy body dementia

    S. van der Zee, Y. Vermeiren, T. Aerts, D. van Dam, M.J. Gerritsen, J.M. Spikman, T. van Laar, P.P. de Deyn (Groningen, Netherlands)

    Objective: The objective of this study was the identification of biochemical markers of cognitive impairment in Parkinson's disease (PD) and dementia with Lewy bodies (DLB)…
  • 2016 International Congress

    Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study

    S. Raha, L. Ebenezer (Bridgend, United Kingdom)

    Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…
  • « Previous Page
  • 1
  • …
  • 120
  • 121
  • 122
  • 123
  • 124
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley